Cardiovascular risk in stage 4 and 5 nephropathy

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Heart disease is a significant concern for patients with chronic kidney disease (CKD).
• The risk of cardiac events and mortality increases with the severity of kidney impairment.
• Heart failure is particularly prevalent and dangerous in severe CKD patients.

Purpose of the Study:

• To summarize the relationship between kidney disease severity and heart disease.
• To discuss risk factors, diagnostic methods, and treatment challenges for heart disease in CKD patients.
• To highlight the inadequate medical therapy for cardiovascular prevention and treatment in this population.

Main Methods:

• Review of existing literature on heart disease in chronic kidney disease.
• Analysis of risk factors, including traditional and nontraditional factors like anemia, inflammation, and thrombotic tendencies.
• Discussion of current screening and diagnostic modalities such as echocardiography, nuclear scintigraphy, and coronary angiography.
• Evaluation of preventive strategies and treatment outcomes.

Main Results:

• Heart disease severity and mortality risk correlate with kidney disease severity.
• Standard and nontraditional risk factors do not fully explain the elevated cardiac risk in severe CKD.
• Patients with CKD exhibit increased risks for contrast-associated nephropathy and may have excessive thrombotic tendencies.
• Current medical therapies for heart disease prevention and treatment are insufficient for CKD patients.

Conclusions:

• There is a strong link between kidney disease progression and increased heart disease risk and mortality.
• A comprehensive understanding of unique risk factors in CKD is crucial for effective management.
• Improved screening, risk stratification, and therapeutic interventions are urgently needed for cardiovascular health in CKD patients.